Abbott Laboratories (ABT)
110.47
+1.54
(+1.41%)
USD |
NYSE |
Sep 02, 16:00
110.63
+0.16
(+0.14%)
After-Hours: 20:00
Abbott Laboratories Cash from Investing (Quarterly) : -673.00M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -673.00M |
| March 31, 2026 | -20.32B |
| December 31, 2025 | -913.00M |
| September 30, 2025 | -457.00M |
| June 30, 2025 | -582.00M |
| March 31, 2025 | -470.00M |
| December 31, 2024 | -866.00M |
| September 30, 2024 | -594.00M |
| June 30, 2024 | -453.00M |
| March 31, 2024 | -425.00M |
| December 31, 2023 | -824.00M |
| September 30, 2023 | -634.00M |
| June 30, 2023 | -1.213B |
| March 31, 2023 | -462.00M |
| December 31, 2022 | -632.00M |
| September 30, 2022 | -484.00M |
| June 30, 2022 | -264.00M |
| March 31, 2022 | -360.00M |
| December 31, 2021 | -671.00M |
| September 30, 2021 | -651.00M |
| June 30, 2021 | -264.00M |
| March 31, 2021 | -422.00M |
| December 31, 2020 | -731.00M |
| September 30, 2020 | -472.00M |
| June 30, 2020 | -619.00M |
| Date | Value |
|---|---|
| March 31, 2020 | -393.00M |
| December 31, 2019 | -489.00M |
| September 30, 2019 | -432.00M |
| June 30, 2019 | -498.00M |
| March 31, 2019 | -396.00M |
| December 31, 2018 | -496.00M |
| September 30, 2018 | -323.00M |
| June 30, 2018 | -299.00M |
| March 31, 2018 | -238.00M |
| December 31, 2017 | -3.152B |
| September 30, 2017 | -306.00M |
| June 30, 2017 | -6.00M |
| March 31, 2017 | -6.154B |
| December 31, 2016 | 1.55B |
| September 30, 2016 | -554.00M |
| June 30, 2016 | -1.47B |
| March 31, 2016 | 226.00M |
| December 31, 2015 | 1.566B |
| September 30, 2015 | -1.197B |
| June 30, 2015 | 242.00M |
| March 31, 2015 | -205.00M |
| December 31, 2014 | -10.00M |
| September 30, 2014 | -825.00M |
| June 30, 2014 | 1.228B |
| March 31, 2014 | -595.00M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Becton, Dickinson & Co. | -228.00M |
| Boston Scientific Corp. | -1.956B |
| DexCom, Inc. | 329.80M |
| Insulet Corp. | -37.40M |
| Intuitive Surgical, Inc. | -26.60M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 2.488B |
| Cash from Financing (Quarterly) | -3.518B |
| Free Cash Flow | 7.824B |
| Free Cash Flow Per Share (Quarterly) | 1.142 |
| Free Cash Flow to Equity (Quarterly) | 3.43B |
| Free Cash Flow to Firm (Quarterly) | 2.191B |
| Free Cash Flow Yield | 4.06% |